Skip the winter sickness wave with six key lifestyle switches

Vitamin D is another one which will regulate your immune system - and as the UK has little daylight sun in winter it’s ...

Wave Life Sciences: 200% Rally On 1% Weight Loss Feels Bloated

Wave Life Sciences' $3.5B valuation reflects both pipeline risk and opportunity. Click here to find out why WVE stock is a Hold.
American Banker

Gould says trust charters have long had nonfiduciary scope

Comptroller of the Currency Jonathan Gould said digital asset firms' trust charter bids fit into the historic scope of the charter, refuting claims that a 2021 interpretive letter he authored as OCC ...
BioSpace

Wave Soars on Early Results for Obesity Treatment That Could ‘Disrupt’ the Landscape

Although still in Phase I, Wave Life Sciences’ injectable RNA weight loss treatment achieved results that impressed analysts, ...

Wave Life Sciences Announces Positive Interim Data from Phase 1 INLIGHT Trial of WVE-007 (INHBE) for Obesity; Single Dose Resulted in Improvement in Body Comp…

Following a single subcutaneous 240 mg dose, WVE-007 (INHBE GalNAc-siRNA) improved body composition at three months compared ...
IEEE

WaveFusion: Wave-Aware Feature Mixing Network for Multisensor Fusion of Infrared and Visible Images

Abstract: Infrared and visible image fusion aims to overcome the limitations of each modality by combining their complementary advantages, thereby enhancing the performance of high-level vision tasks.

Wave Life Sciences: Being Realistic, There Is Still So Much To Prove

Discover why Wave Life Sciences Ltd. is a high-risk, high-reward biotech with unique RNA therapies for AATD, obesity, and ...